People · Operator
Named in public records as an officer, director or promoter · active 2013–2016 · Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioptix Diagnostics, Inc. | — | Other | Series A | $28.0M | $37.3M | 2013 |
| ANDalyze, Inc. | — | Other Technology | Seed | $6.1M | $6.8M | 2016 |
Michael Routh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Routh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kyle Lefkoff | 1 | 9 |
| John Regan | 1 | 7 |
| William Marshall | 1 | 6 |
| John Creecy | 1 | 5 |
| William Coleman | 1 | 5 |
| J. William Freytag | 1 | 4 |
| Dmitry Akhanov | 1 | 4 |
| Ron Van Os | 1 | 3 |
| NOLAN SMITH | 1 | 3 |
| William Thalheimer | 1 | 3 |
| Ron Lowy | 1 | 2 |
| Curt Burwell | 1 | 2 |
| Mikhail Plam | 1 | 2 |
| Richard Whitcomb | 1 | 1 |
| Kevin Brophy | 1 | 1 |
| Ralph W. Dumke | 1 | 1 |
| Yi Lu | 1 | 1 |
| Nancy Sullivan | 1 | 1 |
| Ralph Dumke | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.